Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001337
Status:
COMPLETED
Last Update Posted:
2024-06-18
First Post:
1999-11-03
Brief Title:
Dose-Adjusted EPOCH Chemotherapy and Rituximab CD20 in Previously Untreated Aggressive Non-Hodgkins Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Gray Zone Lymphoma |
| Diffuse Large B-Cell Lymphoma DLBCL |
| Primary Mediastinal Large B-cell Lymphoma |
| Burkitt Lymphoma |
| Anaplastic Large-Cell Lymphoma |